NCT01685424

Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)

Etoricoxib Prescribing Patterns and Adverse Events of Interest During Etoricoxib Treatment in UK Primary Care; an Updated Analysis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 79,189 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This postmarketing study was conducted to describe prescribing patterns for etoricoxib (ARCOXIA®) in General Practice and describe the incidence of selected adverse events recorded in the United Kingdom (UK) Medicines and Health Care Products Regulatory Agency (MHRA) General Practice Research Database (GPRD).

Conditions

• Osteoarthritis
• Rheumatoid Arthritis
• Ankylosing Spondylitis
• Gout
• Arthritis

Interventions

Type	Name	Description
DRUG	Etoricoxib	As per routine clinical practice in the United Kingdom

Timeline

• Start date: 2006-06-30
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2012-09-14
• Last updated: 2022-02-18